NCBiotech News

North Carolina’s strength in the life sciences and its strong business climate have landed it, again, among the nation’s best on Business Facilities Magazine's 16th Annual Rankings Report for 2020.

Greensboro diagnostics and drug screening company Carolina Liquid Chemistries (CLC) is now selling COVID-19 test kits.

The NCBiotech-supported Summer Undergraduate Research Program at Western Carolina University has adapted well to the world of digital communication.

Raleigh pharmaceutical upstart 9 Meters Biopharma has secured patent protection for its potential gastrointestinal drug for additional use in treating lung disease. 

RTP oncology company G1 Therapeutics has out-licensed a potential drug for treating certain breast and lung cancers to a Massachusetts startup in a deal that could be worth more than $300 million.

RTP-based contract research giant IQVIA has launched a program that waives licensing and access fees for approved academic researchers as part of its efforts to accelerate research on how COVID-19 is impacting the healthcare industry and related treatment.

Winston-Salem's EncepHeal Therapeutics has landed a federal grant to support development of its novel medications for cocaine addiction.

Less than two years after launching, Avior Bio is kicking off its first human trial for a novel drug therapy treating pruritus, or chronic itchy skin

RTP-based Panaceutics Nutrition has launched I-Vive, a new line of single-serve nutritional products compounded for the general public

North Carolina’s global leadership in biomanufacturing has drawn another spotlight with a White House announcement that President Donald Trump will be visiting the Triangle on Monday, July 27, to a company involved in producing COVID-19 vaccine.

Boragen, Inc., a boron-based discovery platform company based in RTP, has won a $300,500 Phase I Small Business Innovation Research grant for research on controlling malaria.

Chapel Hill's Path BioAnalytics has joined forces with Australian researchers to study a new drug to fight COVID-19

Winston-Salem's KeraNetics has received FDA approval for its KeraStat Cream to treat debilitating skin burns from radiation therapy.

This month’s NC Biotech Jobs Network featured a panel of three consulting experts who discussed their experiences in starting their own consulting businesses. Panelists included James Iademarco, Principal, Strategic Avalanche LLC; Nannette (Net) Stangle-Castor, Ph.D., President and Founder, InnoVector Tech Inc.; and Scott Rockafellow, President, Granite Beach Management. Each panelist gave a short slide presentation and provided complementary lessons on what is required to become a consultant.